
    
      The study is designed as a prospective observational phase II study with a follow-up period
      of 12 months. Patients diagnosed with early gastric cancer in the distal 2/3rd of the stomach
      who are planned to undergo laparoscopic VPNDG with Roux-en Y gastrojejunostomy will be
      enrolled. Primary endpoint is incidence of dumping syndrome defined by Sigstad score 7 after
      a 3-month interval. Other outcomes include operative data, early complication, and patient
      QOL using the European Organization for Research and Treatment of Cancer C-30 and STO22
      modules.
    
  